(Q44067251)

29 November 2017

Neurotrophin-3 levels in the cerebrospinal fluid of patients with schizophrenia or medical illness (English)

1 reference

29 November 2017

0 references

0 references

Gilmore JH

1

1 reference

29 November 2017

Jarskog LF

2

1 reference

29 November 2017

Lindgren JC

3

1 reference

29 November 2017

McEvoy JP

4

1 reference

29 November 2017

Xiao H

5

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 November 1997

1 reference

29 November 2017

1 reference

29 November 2017

73

1 reference

29 November 2017

1-2

1 reference

29 November 2017

109-113

1 reference

Neurotrophic factors and their receptors

29 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900116-9

7 January 2021

Neurotrophins live or let die: does p75NTR decide?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900116-9

7 January 2021

Transient and persistent expression of NT-3/HDNF mRNA in the rat brain during postnatal development.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900116-9

7 January 2021

Exposure to infection and brain development: cytokines in the pathogenesis of schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900116-9

7 January 2021

Tumor necrosis factor (TNF) stimulates the production of nerve growth factor in fibroblasts via the 55-kDa type 1 TNF receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900116-9

7 January 2021

Association of neurotrophin-3 gene variant with severe forms of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900116-9

7 January 2021

Role of neurotrophic factors in neuronal development.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900116-9

7 January 2021

Developmental changes of neurotrophin-3 level in the mouse brain detected by a highly sensitive enzyme immunoassay.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900116-9

7 January 2021

Tissue distribution and immunocytochemical localization of neurotrophin-3 in the brain and peripheral tissues of rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900116-9

7 January 2021

Multiple sclerosis patients express increased levels of beta-nerve growth factor in cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900116-9

7 January 2021

Neurotrophin-3 (NT-3) levels in the developing rat nervous system and in human samples.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900116-9

7 January 2021

Beta-nerve growth factor as a mediator of the acute phase response in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900116-9

7 January 2021

Nerve growth factor and a fibroblast growth factor-like neurotrophic activity in cerebrospinal fluid of brain injured human patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900116-9

7 January 2021

Accumulation of nerve growth factor in cerebrospinal fluid and biological activity following neurosurgery

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900116-9

7 January 2021

Expression of mRNAs for neurotrophic factors (NGF, BDNF, NT-3, and GDNF) and their receptors (p75NGFR, trkA, trkB, and trkC) in the adult human peripheral nervous system and nonneural tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900116-9

7 January 2021

10.1016/S0165-1781(97)00116-9

Identifiers

DOI

1 reference

29 November 2017

1 reference